Pharmacotherapeutic audit meetings as a tool of improving prescribing practices

Authors

  • Vinod Kumar Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
  • Ravi Kant Director and CEO, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
  • Shailendra Handu Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
  • Jaya Charturvedi Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
  • Ajeet Singh Bhadoria Department of Community and family Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
  • Puneet Dhamija Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20204102

Keywords:

Essential drug list, Generic name, Pharmacotherapeutic audit meeting, Rationality, WHO/INRUD drug prescribing indicators

Abstract

Background: Pharmacotherapeutic audit meeting (PTAM) is a good tool to review prescriptions for rationality and suggest measures for improving quality of prescriptions. To promote this, World Health Organization (WHO) and International Network for Rational Use of Drugs (INRUD) provided drug prescribing and drug use indicators. To assess the impact of PTAMs as an intervention for improving quality and rationality of prescriptions.

Methods: This was a single centre, prospective study conducted from December 2018-February 2020. Prescriptions from outpatient surgical departments were collected, screened using WHO/INRUD core indicators and discussed in PTAMs. The same process was repeated over next 2 months to assess change in prescribing patterns after PTAM. Chi-square and Student’s t-test was used for statistical analysis.

Results: The difference in proportions for antibiotic prescribing was 8.7% [95% CI (1.0%-16.7%), p=0.02]; injectable preparation use was 0.7% [95% CI (-0.4%-2.3%) p=0.23]; prescriptions with generic name drugs was 10.9% [95% CI (5.6-16.2%) p<0.0001] and prescriptions from Essential drug list (EDL) was 8.1% [95% CI (2.5%-13.5%) p=0.0046].

Conclusions: Our research showed PTAM could be an effective tool to implement WHO/INRUD drug prescribing indicators robustly. Hence, it could be included in WHO/INRUD policies as an intricate part of institutional healthcare delivery system.

References

Hogerzeil HV. Promoting rational prescribing: an international perspective. Br J Clin Pharmacol. 1995;39:1-6.

Proceedings of the twentieth anniversary symposium. ATC/DDD classification. WHO Collaborating Centre for Drug Statistics Methodology. WHO Drug Information. 2002;16:3.

Nuthan KUS, Nalini GK, Deepak P, Prema M, Rathod G, Mohith N. Prescription audit of outpatients in tertiary care government hospital. Int J Basic Clin Pharmacol. 2018;7(4):636-9.

El Mahalli AA. WHO/INRUD drug prescribing indicators at primary healthcare centers in eastern Province, Saudi Arabia Eastern Mediterr Health J. 2012;18(11):1091-6.

Harvard Medical School and Harvard Pilgrim Health.Using indicators to measure country pharmaceutical situations. Fact Book on WHO Level I and Level II monitoring indicators. Geneva: World Health Organization; 2006. Available at: https://www.who.int/medicines/publications/WHOTCM2006.2A.pdf Last accessed on 20 June 2020.

Dumoulin J, Kaddar M, Velasquez G. Guide to drug financing mechanisms. Geneva: World Health Organization; 1998. Last accessed on 20 June 2020.

Saha A, Bhattacharjya H, Sengupta B, Debbarma R. Prescription audit in outpatient department of a teaching hospital of North East India. Int J Res Med Sci. 2018; 6(4):1241-7.

Mishra S and Sharma P. Prescription audit and drug utilization pattern in a tertiary care teaching hospital in Bhopal. Int J Basic Clin Pharmacol. 2016;5(5):1845-9.

Patel S, Patel A, Patel V, Solanki M. Study of medication error in hospitalised patients in tertiary care hospital. IJOPP. 2018;11(1):32-6.

Raman V, Sakthi G, Guru R, Ravikumar T, Manjula M, Poongodi P et al. Prescription audit in outpatient departments in tertiary care hospitals -a prospective study. Indian J Basic Appl Med Res. 2018;7(4):354-8.

Ahsan M, Shaifali I, Mallick AK, Singh HK, Verma S, Shekhar A. Prescription auditing based on World Health Organization (WHO) prescribing indicators in a teaching hospital in North India. Int J Med Res Rev. 2016;4(10):1847-52.

Darji NH, Vaniya HV, Doshi CM, Hedamba RH, Jadav SP, Trivedi HR. Prescription audit in the inpatients of a tertiary care hospital attached with medical college. J Clin Exp Res. 2015;3(2):197-200.

Rishi RK, Sangeeta S, Surendra K, Tailang M. Prescription Audit: Experience in Garhwal (Uttaranchal), India. Tropical Doctor. 2003; 33(2):76-9.

Aravamuthan A, Arputhavanan M, Subramaniam K. Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India. J Pharm Policy Pract. 2017;10(1):1.

Abidi A, Gupta S, Kansal S, Ramgopal R. Prescription auditing and drug utilization pattern in a tertiary care teaching hospital of western UP. Int J Basic Clin Pharmacol. 2012;1(3):184-90.

Directorate General of Health Services Ministry of Health & Family Welfare Government of India; National Centre for Disease Control; Version 1.0. 2016. www.pbhealth.gov.in/amr_guideline. Last accessed 20 June 2020.

Downloads

Published

2020-09-22

How to Cite

Kumar, V., Kant, R., Handu, S., Charturvedi, J., Bhadoria, A. S., & Dhamija, P. (2020). Pharmacotherapeutic audit meetings as a tool of improving prescribing practices. International Journal of Basic & Clinical Pharmacology, 9(10), 1587–1593. https://doi.org/10.18203/2319-2003.ijbcp20204102

Issue

Section

Original Research Articles